Skip to content

Medical Cannabis and Breast Cancer

Medical Cannabis and Breast Cancer

October is breast cancer awareness month and we at Arfinn Med would like to reiterate the importance of early screening and regular tests.  According to the American Cancer Society:

“Breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast cancer sometime in her life is about 13%. This means there is a 1 in 8 chance she will develop breast cancer. This also means there is a 7 in 8 chance she will never have the disease.”

Though more studies are needed, we wanted to share some current research about medical marijuana and how it can possibly help breast cancer patients.

According to Virginia F. Borges, M.D., MMSc., professor of medicine and director of the Breast Cancer Research Program at the University of Colorado Cancer Center, she finds that cannabis can help improve some of the symptoms associated the breast cancer treatment.

“I’ve mainly seen it used in conjunction with prescription drugs to control pain and other side effects in patients living with metastatic disease,” she said. “It’s rare that a person living with metastatic breast cancer would have only one side effect to manage. So, by adding in medical marijuana, it often allows me to cut back on the number of drugs I prescribe. With a high-quality source for medical marijuana and knowing how it affects an individual, using medical marijuana can put more control back in the hands of my patient. If someone is feeling good, she may only need to take one or two drops per day. If she’s not feeling good, she may need three or four drops per day. Many of the prescription drugs don’t have this flexibility. Any time you can give control back to a person when their living with cancer, it’s a good thing.”

In addition to helping with the side effects of treatment, some research has shown the ability for cannabidiol (CBD) to actually treat breast cancer itself.  A study published in the journal Molecular Cancer Therapeutics found CBD to be very helpful in inhibiting aggressive cancer cells.

“In the study the team led by senior scientist Dr. Sean D. McAllister used CBD to inhibit the activity of the Id-1 gene, believed to be responsible for cancer cells becoming more aggressive and metastatic. “Metastasis is the final and fatal step in the progression of breast cancer,” the authors write. “Currently available therapeutic strategies at this stage of cancer progression are often nonspecific, have only marginal efficacy and are highly toxic.”

Though cannabinoid medicine has been shown to help with some aspects of breast cancer and the resulting treatment side effects, more research is needed to truly understand its role in the recovery of breast cancer patients.  We hope that as the stigma of medical marijuana disappears, research will be easier to conduct.

In the meantime, please get regular screenings and encourage others to do as well!

Resources:

https://www.breastcancer.org/treatment/comp_med/types/medical-marijuana

https://health.usnews.com/health-care/patient-advice/articles/2017-09-05/can-marijuana-help-with-breast-cancer

https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html

Stories you may be interested in

Updated Arfinn Med Scheduler

As your practice begins to grow, it’s important that your booking system is able to keep up.  That’s why Arfinn Med has just released, in its newest update, the multi-view scheduling and booking platform.  This allows you and/or your staff the ability to customize appointment types, hours of availability, display name, and confirmation emails for…
Read More

Cannabis improves symptoms of Crohn’s disease despite having no effect on gut inflammation

In the first study of its kind, cannabis oil has been shown to significantly improve the symptoms of Crohn’s disease and the quality of life of sufferers but, contrary to previous medical thinking, has no effect on gut inflammation. In a randomised, placebo-controlled study, researchers from Israel have shown that cannabis can produce clinical remission…
Read More

New Feature Updates

It’s a new feature alert! At Arfinn Med we always work to make sure we are the industry leading software platform and EMR for medical cannabis providers and clinics. Keeping with that sentiment, we’ve recently updated two features that have been very popular with Arfinn Med users.  Those are the customizable consent and confirmation page…
Read More

Cannabis and Seniors

As more and more research comes out regarding the medical benefits of cannabis, it’s important to keep up with new research as it becomes available.  Here at Arfinn Med, we constantly review new studies and look at our own deidentified efficacy data to try to find any additional insights we can relay to our registered…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

Arfinn Med Patient Site

We get a lot of interest from patients asking about efficacy data for medical marijuana on a number of conditions. Though we are primarily an electronic medical record (EMR) company focussing on the cannabis industry and other complimentary or alternative therapies, our primary focus is better quality care for patients. So with that being said,…
Read More

Leave a Comment

You must be logged in to post a comment.